Up, Up, and Away
A business analyst rated Baxter stock a strong BUY, as the PD market has an attractive growth rate in the range of 5% to 6%, and the option is flexible and allows a more normal life.
Read the full article » | Posted 07-14-2017
Related Articles
- 30th European Nephrology Conference will be held August 27-28 in Berlin Posted 02-17-2026
- An Australian PD patient developed the free Dialysis Health Tracker app Posted 02-17-2026
- Education Critical to Boosting Home Dialysis, Panel Says I Posted 01-16-2026
- The Annual Dialysis Conference Will be in Kansas City, MO February 26 to March 1 Posted 01-16-2026